Article 05 Jul 2023 At Long Last: FDA Publishes Draft Guidance On The Prohibition On Wholesaling Under Section 503B Of The FDCA United States Healthcare
Article 26 Jun 2023 FDA Finalizes Determinations On 11 Bulk Drug Substances On 503B Bulks List United States Healthcare
Article 15 Mar 2021 Congress Considers The Future Of Telehealth In The Wake Of COVID-19 United States Healthcare
Article 29 Nov 2019 FDA Publishes New Draft Guidance On Animal Drug Compounding United States Healthcare
Article 17 Oct 2019 FDA Partners With The National Association Of Boards Of Pharmacy To Create An Information-Sharing System For Drug Compounding Activities United States Healthcare
Article 07 Oct 2019 Outsourcing Facility Athenex Withdraws Appeal Of District Court's Ruling On FDA's Placement Of Bulk Drug Substances On Its "Clinical Need" List United States Healthcare
Article 26 Apr 2019 FDA Issues 2019 Goals To Improve The Quality Of Compounded Drugs United States Healthcare
Article 12 Dec 2018 FDA Announces Its Plan For Encouraging Reliance On Newer Predicate Devices And Medical Device Performance Criteria United States Healthcare
Article 02 Oct 2017 Recently Released Enhanced Regulatory Initiatives for Drug Compounders United States Healthcare